An exploration of the unanswered questions in how the molecular chaperone Hsp90 supports protein homeostasis, and how single-molecule techniques could drive future breakthroughs in answering them.
For SMX (NASDAQ:SMX), 2024 was a transformative year that captured the market’s attention in unprecedented ways. This was epitomized by SMX stock recording two of the highest single-day trading ...
Dermatologists evaluate moles based on specific criteria when determining whether removal is appropriate. While some patients seek removal for cosmeti ...
Researchers from Mass General Brigham, a health care system in Boston, Massachusetts, shared with Fox News Digital some of the scientific developments and breakthroughs they expect to see in 2025.
Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.